Kailera Therapeutics isn’t the only company developing an obesity drug that hits multiple targets for weight loss, but the clinical-stage biotech believes its lead drug candidate can beat other medicines
FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder
A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a certain inherited immunodeficiency so severe that many babies do not
Everlywell, Jona Team Up to Expand Access to Gut Microbiome Test
Everlywell, an at-home lab testing company, is partnering with AI-powered gut microbiome company Jona to bring a gut microbiome test to consumers nationwide. Everlywell is a direct-to-consumer company selling tests
How Are Health Systems Assessing ROI for AI Tools?
Health systems should use data to identify problems before buying AI tools, according to Arcadia CEO Michael Meucci. The market is flooded with vendors pitching AI solutions — but instead
Democratizing Access: How Community Hospitals Can Drive the Next Wave of Robotic Bronchoscopy
For years, robotic bronchoscopy was confined mainly to elite academic centers and referral hospitals that possessed the budgets, staffing, and infrastructure required to support early-generation systems. That era is ending.
Closing Behavioral Care Gaps: Three Ways Providers And Health Plans Can Reimagine Care
Millions of Americans are struggling to access physical and behavioral healthcare, and providers across the country are overworked, understaffed and face significant economic pressure. Nonetheless, they are expected to innovate
DOJ Cracks Down on Unfair Contracts with New Lawsuit Against NewYork-Presbyterian
The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian Hospital this week, alleging the provider used restrictive payer contracts to block lower-cost plans. The agency claims the health system
UnitedHealthcare Unveils AI Companion to Improve Navigation
UnitedHealthcare launched a generative AI companion on Thursday called Avery, which aims to improve care coordination for members. Avery can support members with a variety of issues like coverage and
Taking a Page From Cancer Drugs, Autoimmune Biotech Alumis Aims for Precision Immunology
Cancer drug research continues to bring patients targeted therapies for tumors that express specific genetic or biological signatures. This precision oncology approach means a clinician can tailor treatment to a
How Real-World Data Is Reshaping the NSCLC Patient Journey
Most pharma companies want to ensure their drugs are effective for the greatest portion of the patient populations they are designed to treat. An important part of designing effective clinical









